Edition:
Deutschland

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

67.23EUR
20 Sep 2019
Change (% chg)

€0.33 (+0.49%)
Prev Close
€66.90
Open
€67.24
Day's High
€67.75
Day's Low
€67.05
Volume
7,164,452
Avg. Vol
3,288,189
52-wk High
€79.95
52-wk Low
€52.02

Select another date:

Fri, Sep 20 2019

European leveraged loan pipeline running dry

LONDON, Sept 20 (LPC) - Europe’s leveraged loan market is digesting around €18bn of new paper, providing a fillip to what has been a quiet year, but once those deals have passed the pipeline looks sparse, prompting concern among bankers that are coming in 40%-50% under budget.

Photo

Biotech is going to the dogs - and big profits await

For Jessica Lescault there is no question that her 6-year old English bulldog "Moose" deserves cutting-edge biotechnology cancer treatment as much as any human patient. | Video

Photo

Factbox: Animal health sector aims to emulate Zoetis biotech leap

A commercial breakthrough in the field of complex therapeutic proteins for dogs by sector leader Zoetis has roused rivals to action in a hunt for biotechnology medicines to treat pets.

Photo

Biotech is going to the dogs - and big profits await

For Jessica Lescault there is no question that her 6-year old English bulldog "Moose" deserves cutting-edge biotechnology cancer treatment as much as any human patient. | Video

Factbox - Animal health sector aims to emulate Zoetis biotech leap

A commercial breakthrough in the field of complex therapeutic proteins for dogs by sector leader Zoetis has roused rivals to action in a hunt for biotechnology medicines to treat pets.

FOCUS-Biotech is going to the dogs - and big profits await

* Immuno-oncology, osteoarthritis biotech drugs in pet pipeline

Photo

Bayer to reduce size of management board to five

FRANKFURT Bayer management board members Hartmut Klusik and Kemal Malik will leave at the end of the year without a replacement, as the German drugmaker reduces its board to five seats to cut costs.

Photo

Bayer to reduce size of management board to five

FRANKFURT Bayer management board members Hartmut Klusik and Kemal Malik will leave at the end of the year without a replacement, as the German drugmaker reduces its board to five seats to cut costs.

UPDATE 1-Bayer to reduce size of management board to five

FRANKFURT, Sept 10 Bayer management board members Hartmut Klusik and Kemal Malik will leave at the end of the year without a replacement, as the German drugmaker reduces its board to five seats to cut costs.

Bayer to reduce size of management board to five

FRANKFURT, Sept 10 Bayer said on Tuesday that management board members Hartmut Klusik and Kemal Malik would leave the company at the end of the year without a replacement, reducing the German drugmaker's board to five seats. (Reporting by Ludwig Burger Editing by Tassilo Hummel)

Select another date: